KLRS
Kalaris Therapeutics
KLRS
KLRS
51 hedge funds and large institutions have $152M invested in Kalaris Therapeutics in 2025 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25.52% more ownership
Funds ownership: 70.7% → 96.22% (+26%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.59M | |
| 2 | +$8.31M | |
| 3 | +$4.48M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.58M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.3M |
Top Sellers
| 1 | -$2.42M | |
| 2 | -$902K | |
| 3 | -$160K | |
| 4 |
Millennium Management
New York
|
-$144K |
| 5 |
Squarepoint
New York
|
-$94.7K |
